pravadoline has been researched along with jwh 018 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hart, R; Huffman, JW; Hurst, DP; Lu, J; Mabon, R; Martin, BR; Reggio, PH; Wiley, JL; Wu, MJ | 1 |
| Black, SL; Gilliam, AF; Hirt, EE; Maitra, R; Mulpuri, Y; Patel, PR; Seltzman, HH; Shiner, C; Snyder, R; Spigelman, I; Thomas, BF | 1 |
2 other study(ies) available for pravadoline and jwh 018
| Article | Year |
|---|---|
3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor.
Topics: Cannabinoids; Cyclohexanols; Dronabinol; Hydrogen Bonding; Indicators and Reagents; Indoles; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Naphthalenes; Receptors, Cannabinoid; Receptors, Drug; Spectrophotometry, Infrared; Stereoisomerism; Structure-Activity Relationship | 2003 |
Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain.
Topics: Animals; CHO Cells; Cricetulus; Dogs; Dose-Response Relationship, Drug; Humans; Male; Molecular Structure; Neuralgia; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2016 |